Personalized medicine in psychiatry
Abbreviation:
Pers. Med. Psychiatry
Published by:
Elsevier Publishing
Publisher Location: Amsterdam, Netherlands
Journal Website:
https://www.sciencedirect.com/journal/personalized-medicine-in-psychiatry/issues
Range of citations in the SafetyLit database:
2021; 27-28 --
2022; 33-34
Publication Date Range:
2017 --
Title began with volume (issue):
1()
Number of articles from this journal included in the SafetyLit database:
2
(Download all articles from this journal in CSV format.)
eISSN = 2468-1717
LCCN = 2018243008 | USNLM = 101699535 | OCLC = 980299026
Find a library that holds this journal: http://worldcat.org/issn/24681717
Journal Language(s):
English
Aims and Scope (from publisher):
Personalized Medicine in Psychiatry provides a home for basic and clinical investigators, neuroscientists, psychiatrists, psychologists, residents, and medical and graduate students to publish high quality research papers, reviews, new ideas and perspectives, debates, case reports, applied technologies that contribute towards advancing our basic, clinical and therapeutic knowledge of personalized medicine in psychiatry.
Personalized medicine in psychiatry seeks to identify factors that contribute to vulnerability to psychiatric disorders and accuracy of diagnosis as well as the major goal of increasing efficacy of therapeutic interventions and decreasing adverse effects by considering the individual characteristics of each patient (e.g. genetics and epigenetics, physiological, endocrinological, psychological, brain imaging and medical comorbidity). Personalized medicine in psychiatry encompasses both which individual should receive what specific type of treatment based on personalized measures, and also identifies those at risk, thereby reducing long-term costs of mental health as well as morbidity.